KyleStricklandMD

Cytopathology, Anatomic Pathology, Clinical Pathology

Physician

Dr. Strickland is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 2015 - 2019
Brigham and Women's HospitalFellowship, Cytopathology, 2015 - 2016
Medical University of South CarolinaClass of 2013

PubMed

Is HER2-Low a New Clinical Entity or Merely a Biomarker for an Antibody Drug Conjugate?
Heidi Ko, Rebecca A Previs, Kyle C Strickland, Jonathan Klein, Brian Caveney
Oncology and Therapy. 2024-03-01
37 citations
Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer.
I-M Launonen, N Lyytikäinen, J Casado, E A Anttila, A Szabó
Nature Communications. 2022-02-11
7 citations
Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis.
Debarati Mukherjee, Rebecca A Previs, Corinne Haines, Muthana Al Abo, Patrick K Juras
Cancer Research. 2023-09-01

Journal Articles

Original Contribution Clinicopathologic and Immunohistochemical Features of Uterine Adenomyomatous Polyps☆
Bradley J Quade, Brooke E Howitt, Marisa R Nucci, Kyle C Strickland, ScienceDirect